SEMLER SCIENTIFIC INC (SMLR) Stock Fundamental Analysis

NASDAQ:SMLR • US81684M1045

20.33 USD
-1.04 (-4.87%)
At close: Jan 15, 2026
20.33 USD
0 (0%)
After Hours: 1/15/2026, 8:17:24 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SMLR. SMLR was compared to 185 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of SMLR while its profitability can be described as average. SMLR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • SMLR had positive earnings in the past year.
  • In the past year SMLR has reported a negative cash flow from operations.
  • Each year in the past 5 years SMLR has been profitable.
  • SMLR had a positive operating cash flow in each of the past 5 years.
SMLR Yearly Net Income VS EBIT VS OCF VS FCFSMLR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

1.2 Ratios

  • SMLR has a Return On Assets of 8.10%. This is amongst the best in the industry. SMLR outperforms 89.25% of its industry peers.
  • The Return On Equity of SMLR (10.51%) is better than 87.10% of its industry peers.
Industry RankSector Rank
ROA 8.1%
ROE 10.51%
ROIC N/A
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)N/A
ROIC(5y)N/A
SMLR Yearly ROA, ROE, ROICSMLR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800 1K

1.3 Margins

  • The Profit Margin of SMLR (130.80%) is better than 99.46% of its industry peers.
  • In the last couple of years the Profit Margin of SMLR has grown nicely.
  • SMLR's Operating Margin has improved in the last couple of years.
  • SMLR has a Gross Margin of 90.83%. This is amongst the best in the industry. SMLR outperforms 97.31% of its industry peers.
  • SMLR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 130.8%
GM 90.83%
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
SMLR Yearly Profit, Operating, Gross MarginsSMLR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

3

2. Health

2.1 Basic Checks

  • SMLR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for SMLR has been increased compared to 1 year ago.
  • Compared to 5 years ago, SMLR has more shares outstanding
  • SMLR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SMLR Yearly Shares OutstandingSMLR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
SMLR Yearly Total Debt VS Total AssetsSMLR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • SMLR has an Altman-Z score of 1.72. This is a bad value and indicates that SMLR is not financially healthy and even has some risk of bankruptcy.
  • SMLR has a Altman-Z score of 1.72. This is comparable to the rest of the industry: SMLR outperforms 55.91% of its industry peers.
  • SMLR has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
  • SMLR has a Debt to Equity ratio (0.25) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z 1.72
ROIC/WACCN/A
WACC10%
SMLR Yearly LT Debt VS Equity VS FCFSMLR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 1.97 indicates that SMLR should not have too much problems paying its short term obligations.
  • SMLR has a Current ratio of 1.97. This is in the lower half of the industry: SMLR underperforms 61.29% of its industry peers.
  • SMLR has a Quick Ratio of 1.95. This is a normal value and indicates that SMLR is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.95, SMLR is in line with its industry, outperforming 54.30% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.97
Quick Ratio 1.95
SMLR Yearly Current Assets VS Current LiabilitesSMLR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

4

3. Growth

3.1 Past

  • SMLR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 220.88%, which is quite impressive.
  • The Earnings Per Share has been growing by 24.17% on average over the past years. This is a very strong growth
  • The Revenue for SMLR has decreased by -37.30% in the past year. This is quite bad
  • Measured over the past years, SMLR shows a quite strong growth in Revenue. The Revenue has been growing by 11.43% on average per year.
EPS 1Y (TTM)220.88%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%48.61%
Revenue 1Y (TTM)-37.3%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-44.56%

3.2 Future

  • The Earnings Per Share is expected to decrease by -29.01% on average over the next years. This is quite bad
  • SMLR is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -16.29% yearly.
EPS Next Y-95.59%
EPS Next 2Y-87.87%
EPS Next 3Y-29.01%
EPS Next 5YN/A
Revenue Next Year-43.2%
Revenue Next 2Y-30.37%
Revenue Next 3Y-16.29%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SMLR Yearly Revenue VS EstimatesSMLR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
SMLR Yearly EPS VS EstimatesSMLR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

4

4. Valuation

4.1 Price/Earnings Ratio

  • SMLR is valuated cheaply with a Price/Earnings ratio of 2.32.
  • Based on the Price/Earnings ratio, SMLR is valued cheaper than 99.46% of the companies in the same industry.
  • SMLR is valuated cheaply when we compare the Price/Earnings ratio to 26.99, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 249.14 indicates a quite expensive valuation of SMLR.
  • Based on the Price/Forward Earnings ratio, SMLR is valued a bit cheaper than 65.05% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, SMLR is valued quite expensively.
Industry RankSector Rank
PE 2.32
Fwd PE 249.14
SMLR Price Earnings VS Forward Price EarningsSMLR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SMLR Per share dataSMLR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • SMLR has a very decent profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as SMLR's earnings are expected to decrease with -29.01% in the coming years.
PEG (NY)N/A
PEG (5Y)0.1
EPS Next 2Y-87.87%
EPS Next 3Y-29.01%

0

5. Dividend

5.1 Amount

  • SMLR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

SEMLER SCIENTIFIC INC

NASDAQ:SMLR (1/15/2026, 8:17:24 PM)

After market: 20.33 0 (0%)

20.33

-1.04 (-4.87%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12
Earnings (Next)02-16
Inst Owners65.81%
Inst Owner Change-8.45%
Ins Owners4.75%
Ins Owner Change0%
Market Cap308.20M
Revenue(TTM)36.96M
Net Income(TTM)48.34M
Analysts82.22
Price Target66.98 (229.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1964.05%
Min EPS beat(2)1930.07%
Max EPS beat(2)1998.04%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.59%
Min Revenue beat(2)-6.63%
Max Revenue beat(2)-0.56%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-12.83%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.61%
Valuation
Industry RankSector Rank
PE 2.32
Fwd PE 249.14
P/S 8.34
P/FCF N/A
P/OCF N/A
P/B 0.67
P/tB N/A
EV/EBITDA N/A
EPS(TTM)8.76
EY43.09%
EPS(NY)0.08
Fwd EY0.4%
FCF(TTM)-1.79
FCFYN/A
OCF(TTM)-1.78
OCFYN/A
SpS2.44
BVpS30.33
TBVpS-5.28
PEG (NY)N/A
PEG (5Y)0.1
Graham Number77.31
Profitability
Industry RankSector Rank
ROA 8.1%
ROE 10.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 130.8%
GM 90.83%
FCFM N/A
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)23.58%
ROCE(5y)33.24%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
F-Score2
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 55.77%
Cap/Sales 0.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.97
Quick Ratio 1.95
Altman-Z 1.72
F-Score2
WACC10%
ROIC/WACCN/A
Cap/Depr(3y)171.05%
Cap/Depr(5y)155.18%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.73%
Profit Quality(3y)88.64%
Profit Quality(5y)91.36%
High Growth Momentum
Growth
EPS 1Y (TTM)220.88%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%48.61%
EPS Next Y-95.59%
EPS Next 2Y-87.87%
EPS Next 3Y-29.01%
EPS Next 5YN/A
Revenue 1Y (TTM)-37.3%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-44.56%
Revenue Next Year-43.2%
Revenue Next 2Y-30.37%
Revenue Next 3Y-16.29%
Revenue Next 5YN/A
EBIT growth 1Y-126.25%
EBIT growth 3Y2.48%
EBIT growth 5Y14.34%
EBIT Next Year-354.87%
EBIT Next 3Y-51.48%
EBIT Next 5YN/A
FCF growth 1Y-262.46%
FCF growth 3Y16.95%
FCF growth 5Y17.17%
OCF growth 1Y-244.7%
OCF growth 3Y14.98%
OCF growth 5Y13.91%

SEMLER SCIENTIFIC INC / SMLR FAQ

What is the ChartMill fundamental rating of SEMLER SCIENTIFIC INC (SMLR) stock?

ChartMill assigns a fundamental rating of 4 / 10 to SMLR.


Can you provide the valuation status for SEMLER SCIENTIFIC INC?

ChartMill assigns a valuation rating of 4 / 10 to SEMLER SCIENTIFIC INC (SMLR). This can be considered as Fairly Valued.


How profitable is SEMLER SCIENTIFIC INC (SMLR) stock?

SEMLER SCIENTIFIC INC (SMLR) has a profitability rating of 6 / 10.


What is the financial health of SEMLER SCIENTIFIC INC (SMLR) stock?

The financial health rating of SEMLER SCIENTIFIC INC (SMLR) is 3 / 10.